Engineered fatty acid biosynthesis in Streptomyces by altered catalytic function of β-ketoacyl-acyl carrier protein synthase III

被引:23
|
作者
Smirnova, N
Reynolds, KA
机构
[1] Virginia Commonwealth Univ, ISBDD, Richmond, VA 23219 USA
[2] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA
关键词
D O I
10.1128/JB.183.7.2335-2342.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Streptomyces glaucescens beta -ketoacyl-acyl carrier protein (ACP) synthase III (KASIII) initiates straight- and branched-chain fatty acid biosynthesis by catalyzing the decarboxylative condensation of malonyl-ACP with different acyl-coenzyme A (CoA) primers. This KASIII has one cysteine residue, which is critical for forming an acyl-enzyme intermediate in the first step of the process. Three mutants (Cys122Ala, Cys122Ser, Cys122Gln) were created by site-directed mutagenesis, Plasmid-based expression of these mutants in S. glaucescens resulted in strains which generated 75 (Cys122Ala) to 500% (Cys122Gln) more straight-chain fatty acids (SCFA) than the corresponding wild-type strain. In contrast, plasmid-based expression of wild-type KASIII had no effect on fatty acid profiles. These observations are attributed to an uncoupling of the condensation and decarboxylation activities in these mutants (malonyl-ACP is thus converted to acetyl-ACP, a SCFA precursor). Incorporation experiments with perdeuterated acetic acid demonstrated that 9% of the palmitate pool of the wild-type strain was generated from an intact D-3 acetyl-CoA starter unit, compared to 3% in a strain expressing the Cys122Gln KASIII. These observations support the intermediacy of malonyl-ACP in generating the SCFA precursor in a strain expressing this mutant. To study malonyl-ACP decarboxylase activity in vitro, the KASIII mutants were expressed and purified as His-tagged proteins in Escherichia coli and assayed. In the absence of the acyl-CoA substrate the Cys122Gln mutant and wild-type KASIII were shown to have comparable decarboxylase activities in vitro. The Cys122Ala mutant exhibited higher activity. This activity was inhibited for all enzymes by the presence of high concentrations of isobutyryl-CoA (>100 muM), a branched chain fatty acid biosynthetic precursor. Under these conditions the mutant enzymes had no activity, while the wild-type enzyme functioned as a ketoacyl synthase. These observations indicate the likely upper and lower limits of isobutyryl-CoA and related acyl-CoA concentrations,within S. glaucescens.
引用
收藏
页码:2335 / 2342
页数:8
相关论文
共 50 条
  • [41] β-ketoacyl-acyl carrier protein synthase IV:: a key enzyme for regulation of medium-chain fatty acid synthesis in Cuphea lanceolata seeds
    Schütt, BS
    Abbadi, A
    Loddenkötter, B
    Brummel, M
    Spener, F
    PLANTA, 2002, 215 (05) : 847 - 854
  • [42] β-Ketoacyl-acyl carrier protein synthase IV: a key enzyme for regulation of medium-chain fatty acid synthesis in Cuphea lanceolata seeds
    Burkhardt Schütt
    Amine Abbadi
    Brigitte Loddenkötter
    Monika Brummel
    Friedrich Spener
    Planta, 2002, 215 : 847 - 854
  • [43] Structural modeling and site-directed mutagenesis of the actinorhodin β-ketoacyl-acyl carrier protein synthase
    He, M
    Varoglu, M
    Sherman, DH
    JOURNAL OF BACTERIOLOGY, 2000, 182 (09) : 2619 - 2623
  • [44] Structure of the complex between the antibiotic cerulenin and its target, β-ketoacyl-acyl carrier protein synthase
    Moche, M
    Schneider, G
    Edwards, P
    Dehesh, K
    Lindqvist, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6031 - 6034
  • [45] Crystal structure of a substrate complex of Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A
    Musayev, F
    Sachdeva, S
    Scarsdale, JN
    Reynolds, KA
    Wright, HT
    JOURNAL OF MOLECULAR BIOLOGY, 2005, 346 (05) : 1313 - 1321
  • [46] β-Ketoacyl-acyl Carrier Protein Synthase I (KASI) Plays Crucial Roles in the Plant Growth and Fatty Acids Synthesis in Tobacco
    Yang, Tianquan
    Xu, Ronghua
    Chen, Jianghua
    Liu, Aizhong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08)
  • [47] Synthesis of C(7) modified chrysin derivatives designing to inhibit β-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics
    Li, Huan-Qiu
    Shi, Lei
    Li, Qing-Shan
    Liu, Peng-Gang
    Luo, Yin
    Zhao, Jing
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (17) : 6264 - 6269
  • [48] Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
    Wang, Xiao-Liang
    Zhang, Yan-Bin
    Tang, Jian-Feng
    Yang, Yu-Shun
    Chen, Ruo-Qi
    Zhang, Fei
    Zhu, Hai-Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 57 : 373 - 382
  • [49] A combined approach of docking and 3D QSAR study of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
    Ashek, A
    Cho, SJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (05) : 1474 - 1482
  • [50] Probing the mechanism of the Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III mtFabH -: Factors influencing catalysis and substrate specificity
    Brown, AK
    Sridharan, S
    Kremer, L
    Lindenberg, S
    Dover, LG
    Sacchettini, JC
    Besra, GS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (37) : 32539 - 32547